Finally, and in order to clarify if direct CTH inhibition on the tumor cells could trigger any additional anti-tumoral effects, human and mouse GBM cells were treated with pharmacological (PAG) or molecular (siRNA) CTH inhibitors. This evidence concerns the gene CTH and glioblastoma.